Advancell Overview

Advancell is a Spanish Biotech Company Leader in Nanomedicine

The company has two divisions: Pharma, which focuses its activity on the development of innovative drugs through the search for new applications for already-known molecules, and Services and Reagents, which uses cell-based in vitro methods to predict the efficacy, safety and mechanism of action of developing molecules. Advancell's...More»

Advancell is a Spanish Biotech Company Leader in Nanomedicine

The company has two divisions: Pharma, which focuses its activity on the development of innovative drugs through the search for new applications for already-known molecules, and Services and Reagents, which uses cell-based in vitro methods to predict the efficacy, safety and mechanism of action of developing molecules. Advancell's business model allows it to achieve substantial reductions in costs, risks and the development time of a drug.

Advancell is a world leader in nanomedicine, the science that uses technologies at the nanometric (less then a millionth of a millimeter) scale to diagnose, treat and prevent diseases. The most advanced project is focused on nanomedicines for the topical treatment of psoriasis and other skin diseases. In addition, Advancell is developing a new "orphan drug" for Chronic Lymphocytic Leukaemia and an adjuvant treatment for depression, which is currently in the clinical phase II.«Less